CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-03-31 |
|---|---|---|
Revenue | $52 | $83 |
Gross Profit | 82 | |
EBITDA | -1,071 | -549 |
EBIT | -611 | |
Net Income | -1,077 | -403 |
Net Change In Cash | 52 | 83 |
Free Cash Flow | -1,468 | -765 |
Cash | 3,443 | 4,798 |
Basic Shares | 11,540 | 11,539 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $52 | $290 | $270 | $84 |
Gross Profit | -515 | 213 | 263 | 81 |
EBITDA | -1,790 | -2,937 | -1,110 | -1,188 |
EBIT | -1,882 | -3,015 | -1,402 | -1,432 |
Net Income | -1,883 | -3,131 | -2,397 | -1,533 |
Net Change In Cash | 52 | 290 | 270 | 84 |
Free Cash Flow | -2,742 | -2,636 | -1,390 | -1,697 |
Cash | 3,443 | 8,995 | 1,173 | 1,858 |
Basic Shares | 11,539 | 10,630 | 7,915 | 6,934 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-03-31 | -$0.12 |
2024-09-30 | -$0.04 |
2024-06-30 | -$0.09 |
